N Ravenscroft
Overview
Explore the profile of N Ravenscroft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ravenscroft N, Cescutti P, Gavini M, Stefanetti G, MacLennan C, Martin L, et al.
Carbohydr Res
. 2015 Feb;
404:108-16.
PMID: 25665787
Salmonella paratyphi A is increasingly recognized as a common cause of enteric fever cases and there are no licensed vaccines against this infection. Antibodies directed against the O-polysaccharide of the...
2.
Ravenscroft N, Jones C
Curr Opin Drug Discov Devel
. 2009 Aug;
3(2):222-31.
PMID: 19649853
Licensed glycoconjugate vaccines provide protective immunity against bacterial pathogens by eliciting a T-cell-dependent immune response to the corresponding bacterial saccharide covalently linked to a protein carrier. The field is rapidly...
3.
Ricci S, Bardotti A, DAscenzi S, Ravenscroft N
Vaccine
. 2001 Mar;
19(15-16):1989-97.
PMID: 11228369
A new method for the quantitative determination of Neisseria meningitidis group A (MenA) capsular polysaccharide (CPS) has been developed. The method is based on trifluoracetic acid (TFA) hydrolysis of the...
4.
Ravenscroft N, DAscenzi S, Proietti D, Norelli F, Costantino P
Dev Biol (Basel)
. 2001 Feb;
103:35-47.
PMID: 11214252
Glycoconjugate vaccines are being developed against Haemophilus influenzae (Hib) and meningococcal Type A and C micro-organisms; they consist of oligosaccharides of intermediate chain length conjugated to the carrier protein CRM...
5.
Ceccarini C, Contorni M, Costantino P, DAscenzi S, Gallo E, Maffei M, et al.
Dev Biol (Basel)
. 2001 Feb;
103:175-88.
PMID: 11214235
The characterisation of an acellular pertussis vaccine composed of a genetically modified pertussis toxin, filamentous haemagglutinin and pertactin is described. The three antigens are submitted to a mild treatment with...
6.
Gamian A, Jones C, Lipinski T, Korzeniowska-Kowal A, Ravenscroft N
Eur J Biochem
. 2000 May;
267(11):3160-7.
PMID: 10824100
Lipopolysaccharide was extracted from cells of Salmonella enterica serovar Toucra O48 and, after mild acid hydrolysis (1% AcOH, 1 h, 100 degrees C or 0.1 M NaOH-AcOH, pH 4.5, 5...
7.
Ravenscroft N, Averani G, Bartoloni A, Berti S, Bigio M, Carinci V, et al.
Vaccine
. 1999 Aug;
17(22):2802-16.
PMID: 10438050
We recently described the use of ion exchange chromatography for analysis and the industrial scale preparation of pools of oligosaccharides of intermediate chain length from polysaccharides of Haemophilus influenzae type...
8.
Costantino P, Norelli F, Giannozzi A, DAscenzi S, Bartoloni A, Kaur S, et al.
Vaccine
. 1999 Apr;
17(9-10):1251-63.
PMID: 10195638
We have developed a chromatographic method suitable for the fractionation of polysaccharides having a negatively charged group. The method permits the removal of all those polysaccharide fragments having a short...
9.
Granoff D, Bartoloni A, Ricci S, Gallo E, Rosa D, Ravenscroft N, et al.
J Immunol
. 1998 May;
160(10):5028-36.
PMID: 9590252
The poor immunogenicity of the Neisseria meningitidis group B polysaccharide capsule, a homopolymer of alpha(2-->8) sialic acid, has been attributed to immunologic tolerance induced by prenatal exposure to host polysialyated...
10.
Ravenscroft N, Dabrowski J, Romanowska E
Eur J Biochem
. 1995 Apr;
229(1):299-307.
PMID: 7744044
Sugar analysis of the O-specific polysaccharide produced by Citrobacter serotype O41 revealed the presence of a hexasaccharide repeating unit, which includes the unusual 3-amino-N-(D-3'-hydroxybutyryl)-3,6-dideoxy-D-galactosyl residue (Fuc3NAcyl). The structure of the...